Steroids and severe pneumonia. Ready for the winter? Discussion on “Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study”
Author:
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Link
http://link.springer.com/article/10.1007/s00134-018-5414-3/fulltext.html
Reference7 articles.
1. Moreno G, Rodríguez A, Reyes LF, GETGAG Study Group et al (2018) Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med 44:1470–1482. https://doi.org/10.1007/s00134-018-5332-4
2. Torres A, Ferrer M, Niederman MS (2018) Adjuvant therapies in critical care: steroids in community-acquired pneumonia. Intensive Care Med 44:478–481
3. Sakr Y, Ferrer R, Reinhart K, IC-GLOSSARI Investigators, ESICM Trials Group et al (2016) The intensive care global study on severe acute respiratory infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study. Intensive Care Med 42:817–828
4. Torres A, Martín-Loeches I, Menéndez R (2017) Research in community-acquired pneumonia: the next steps. Intensive Care Med 43:1395–1397. https://doi.org/10.1007/s00134-017-4774-4
5. Torres A, Sibila O, Ferrer M et al (2015) Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 313:677–686. https://doi.org/10.1001/jama.2015.88
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients;Medicina Intensiva (English Edition);2023-01
2. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients;Medicina Intensiva;2021-10
3. Rationality of Time-Dependent Antimicrobial Use in Intensive Care Units in China: A Nationwide Cross-Sectional Survey;Frontiers in Medicine;2021-02-17
4. A Comprehensive Summary of the Knowledge on COVID-19 Treatment;Aging and disease;2021
5. A literature review of drugs for the treatment of COVID-19;Caribbean Medical Journal;2020-05-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3